Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Thrombopoietin mimetics in development at GSK

July 4, 2001

Insulin sensitization with rosiglitazone may have numerous beneficial effects

July 4, 2001

Nexell submits IND for blood stem cell therapy as treatment of CGD

July 4, 2001

Potent analogues of hPTH and hPTHrP with bone anabolic effects

July 4, 2001

Glycogen synthase 3 as a novel therapeutic target in type 2 diabetes

July 4, 2001

Novavax seeks approval of Estrasorb in U.S.; expands license agreement with King

July 3, 2001

New AGE production inhibitor with promise in diabetic nephropathy

July 3, 2001

ADA news: glycemic control and lipid profiles improve on INS-1 + sulfonylurea in type 2 diabetes

July 3, 2001

Metabolex/Pfizer diabetes partnership gains new focus

July 3, 2001

Potential of topiramate for diabetes explored using animal models

July 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...